Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:10 AM
Ignite Modification Date:
2025-12-26 @ 11:10 AM
NCT ID:
NCT06816212
Eligibility Criteria:
Inclusion Criteria:
* Prospective cohort patients voluntarily sign the informed consent form.
* Patients with a history of malignant tumors, CE-MRI indicated the presence of HPD in the liver.
* The shape of HPD is nodular.
* The diameter of HPD is greater than 10mm.
* The main large vessels in the liver are clearly displayed in the MRI.
Exclusion Criteria:
* Patients who unable to complete imaging examinations, such as severe cardiac insufficiency, severe renal insufficiency, hypersensitivity to contrast agents or adverse reactions to them, etc.
* Patients with the history of extensive liver resection or liver transplantation.
* Patients whose abdomen with abundant intestinal gas.
Sex:
ALL
Study:
NCT06816212
Study Brief:
Protocol Section:
NCT06816212